Alzheimer’s disease is widely known for its most visible symptoms, such as memory loss, confusion, and difficulty thinking clearly. These changes often appear slowly and become worse over time.
However, scientists now know that the disease does not start when memory problems first appear. Instead, changes in the brain can begin many years, and sometimes even decades, earlier.
Before people develop noticeable memory problems, they may experience other symptoms that are easy to overlook. These can include trouble sleeping, increased anxiety, depression, and changes in mood or attention.
Because these symptoms do not immediately suggest Alzheimer’s disease, they are often not connected to the illness. Researchers believe these early signs may actually reflect the first damage happening deep inside the brain.
A new study led by scientists at the University of California, San Francisco (UCSF) may help explain why some brain cells begin to fail so early in Alzheimer’s disease. The research suggests that the way certain neurons handle cholesterol may determine how vulnerable they are to damage from the disease.
The study was carried out by researchers at UCSF’s Memory and Aging Center and was published on March 26 in the scientific journal Alzheimer’s & Dementia. The research team wanted to understand why some parts of the brain show signs of Alzheimer’s very early, while other nearby regions remain relatively protected for a long time.
To answer this question, the scientists examined two specific brain regions taken from the same individuals.
One region is usually affected very early in Alzheimer’s disease, while the other tends to resist damage. By comparing these two regions side by side, the researchers hoped to identify biological differences that might explain why some neurons are more fragile.
The brain samples used in the study came from two important research collections. One was the Neurodegenerative Disease Brain Bank at UCSF, and the other was the Biobank for Aging Studies at the University of São Paulo in Brazil.
These collections allow scientists to study brain tissue from people who donated their brains for research after death, helping researchers understand how neurological diseases develop.
From each brain, the researchers examined two regions. The first region was the Locus Coeruleus, often shortened to LC. This small area of the brain produces a chemical messenger called noradrenaline.
The LC is known to help control sleep, attention, mood, and the body’s response to stress. Previous research has shown that this region is one of the very first areas damaged in Alzheimer’s disease.
The second region the scientists studied was the Substantia Nigra, often called the SN. This region produces dopamine, a chemical involved in movement and motivation.
The SN is more closely linked with Parkinson’s disease, but it usually remains much less affected by Alzheimer’s disease. Although these two brain regions share several similarities in structure and function, they respond very differently when Alzheimer’s develops.
The researchers wanted to understand why this difference exists. To do this, they studied gene activity inside the neurons from each brain region using a technique known as RNA analysis. This method allows scientists to see which genes are active and what processes the cells are carrying out.
The results revealed an important difference in how the neurons handle cholesterol. Cholesterol is often thought of as something harmful when found at high levels in the blood, but it also plays an important role in the brain. Brain cells use cholesterol to build and maintain cell membranes and to support communication between neurons.
The scientists discovered that neurons in the Locus Coeruleus seem to require much more cholesterol than neurons in the Substantia Nigra. According to the researchers, LC neurons both produce their own cholesterol and absorb extra cholesterol from their surroundings at much higher levels.
The study found that LC neurons contain larger amounts of a protein called LDLR, which stands for low-density lipoprotein receptor. This protein helps cells absorb cholesterol from outside the cell. While this process normally helps neurons function properly, it may also create a problem in Alzheimer’s disease.
The same receptor that allows cholesterol to enter the cell may also allow harmful substances to enter.
In particular, small toxic clusters of amyloid-beta proteins, which are strongly linked to Alzheimer’s disease, may be able to enter neurons through these receptors. These protein clumps are believed to damage brain cells and contribute to the progression of Alzheimer’s.
In contrast, neurons in the Substantia Nigra appear to have a natural protective system. These cells produce higher levels of another molecule that helps break down LDL receptors. By reducing the number of receptors on the cell surface, these neurons may limit the entry of harmful amyloid-beta proteins.
The researchers confirmed these differences using a laboratory method called immunohistochemistry. This technique allows scientists to visually detect specific proteins inside cells. Their analysis clearly showed that LC neurons contained higher levels of LDL receptors than SN neurons.
Senior author Dr. Lea Grinberg, a professor of neurology and pathology at UCSF, explained that this discovery may help answer one of the long-standing questions in Alzheimer’s research. Scientists have long wondered why certain neurons are damaged very early in the disease while others remain relatively protected.
The findings suggest that differences in cholesterol regulation could make some neurons much more vulnerable. Because the Locus Coeruleus plays a major role in sleep regulation, attention, and mood, damage in this region could explain why sleep disturbances, anxiety, and emotional changes often appear long before memory problems.
The research also identified other biological differences between the two brain regions, including how they handle metals and respond to cellular stress. However, cholesterol metabolism stood out as one of the most important clues.
Understanding these early changes could be extremely important for developing new treatments. If scientists can find ways to control how neurons use cholesterol or prevent harmful proteins from entering cells through cholesterol receptors, it may be possible to slow the earliest stages of Alzheimer’s disease.
Although more research is needed to confirm these findings in living patients, the study provides an important step toward understanding how Alzheimer’s begins. By focusing on the earliest vulnerable brain cells, scientists hope to develop treatments that protect the brain before major damage occurs.
If you care about Alzheimer’s disease, please read studies about the protective power of dietary antioxidants against Alzheimer’s, and eating habits linked to higher Alzheimer’s risk.
For more health information, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
The research findings can be found in Alzheimer’s & Dementia.
Copyright © 2026 Knowridge Science Report. All rights reserved.
